# Porcine Hypothalamus Extract (Sus scrofa domesticus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/porcine-hypothalamus-extract
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-25
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** Sus scrofa domesticus hypothalamus, Pig hypothalamus extract, Swine hypothalamus, Porcine brain extract, PHE, Hypothalamic tissue extract, Neuroendocrine glandular

## Overview

Porcine hypothalamus extract is derived from pig (Sus scrofa domesticus) hypothalamic tissue and contains bioactive neuropeptides including corticotropin-releasing factor (CRF) and somatostatin that interact with pituitary receptors to modulate stress hormone cascades. Its primary proposed mechanism involves supporting the [hypothalamic-pituitary-adrenal](/ingredients/condition/stress) (HPA) axis by providing exogenous neuropeptide precursors and antimitogenic peptides identified in early research.

## Health Benefits

• May support pituitary-adrenal axis function through corticotropin-releasing factor (CRF) activity (evidence: in vitro and animal studies only)
• Contains antimitogenic peptides that may inhibit abnormal cell growth (evidence: preliminary in vitro studies)
• Potential neuroendocrine support through prolactin-modulating factors (evidence: basic science research only)
• May influence stress hormone regulation via ACTH stimulation (evidence: rat studies only)
• Contains enkephalin peptides that could affect pain and mood pathways (evidence: biochemical characterization only)

## Mechanism of Action

Porcine hypothalamus extract contains corticotropin-releasing factor (CRF), which binds CRF receptor type 1 (CRFR1) on anterior pituitary corticotrophs to stimulate ACTH synthesis and secretion, thereby modulating [cortisol](/ingredients/condition/stress) output from the adrenal cortex. Somatostatin and thyrotropin-releasing hormone (TRH) present in the extract act on somatostatin receptors (SSTRs) and TRH receptors respectively, potentially modulating growth hormone and [thyroid](/ingredients/condition/hormonal)-stimulating hormone release. Antimitogenic peptides identified in hypothalamic fractions have shown inhibitory activity on cell proliferation in vitro, possibly through interference with cyclin-dependent kinase pathways, though the precise molecular targets in humans remain uncharacterized.

## Clinical Summary

Human clinical evidence for porcine hypothalamus extract is essentially absent; existing data derives from in vitro cell culture experiments and rodent studies conducted primarily in the 1970s–1990s. Animal studies demonstrated measurable [HPA axis](/ingredients/condition/stress) modulation following hypothalamic peptide administration, but doses and delivery routes (often direct intracerebroventricular injection) bear no resemblance to oral supplement use. Antimitogenic activity was identified in bovine and porcine hypothalamic fractions in cell-line studies, but no controlled human trials have quantified clinical outcomes for commercially available oral extracts. The overall evidence base is preliminary and insufficient to establish efficacy, therapeutic dosing, or clinically meaningful benefit in healthy adults.

## Nutritional Profile

Porcine hypothalamus extract is a protein-dominant tissue extract with the following characterized components: Protein content comprises approximately 60-75% of dry weight, consisting of structural proteins, neuropeptides, and bioactive peptides. Key bioactive peptides identified include corticotropin-releasing factor/hormone (CRF/CRH) at trace concentrations (endogenous tissue levels ~1-10 pmol/g wet tissue), thyrotropin-releasing hormone (TRH) at approximately 2-5 pmol/g wet tissue, gonadotropin-releasing hormone (GnRH) at ~0.5-2 pmol/g wet tissue, somatostatin (growth hormone-inhibiting hormone) at ~10-50 pmol/g wet tissue, and prolactin-inhibiting factors (including [dopamine](/ingredients/condition/mood)rgic peptides). Growth hormone-releasing hormone (GHRH) is present at approximately 1-5 pmol/g wet tissue. Lipid content is approximately 10-20% of dry weight, inclusive of phospholipids (phosphatidylcholine, phosphatidylethanolamine) and cholesterol inherent to neural tissue membranes. Glycoprotein-bound carbohydrates constitute roughly 2-5% of dry weight. Micronutrients reflect neural tissue composition: zinc (approximately 15-25 mcg/g dry weight), iron (~20-40 mcg/g dry weight), copper (~3-6 mcg/g dry weight), and magnesium (~200-400 mcg/g dry weight). B-vitamins are present at low concentrations consistent with neural tissue (B12 ~0.1-0.3 mcg/g, niacin ~5-15 mcg/g, B6 ~2-5 mcg/g dry weight). Bioavailability note: Oral bioavailability of intact neuropeptides is considered very low due to proteolytic degradation in the GI tract; smaller peptide fragments and amino acid constituents are the primary absorbed species. Antimitogenic peptide fractions have been partially characterized in the 1,000-5,000 Da molecular weight range. Amino acid profile reflects CNS tissue with notable concentrations of glutamate, aspartate, glycine, and taurine as dominant free amino acids.

## Dosage & Preparation

No clinically studied dosage ranges for porcine hypothalamus extract in humans have been established. In vitro studies used 50-200 μg/ml of purified CRF fractions in rat models. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Porcine hypothalamus extract is contraindicated in individuals with known pork or porcine tissue hypersensitivity, as cross-reactive allergenic proteins may trigger immune responses. There is a theoretical prion transmission risk associated with all mammalian CNS-derived glandular products, though commercial manufacturers typically employ acid-ethanol fractionation and heat processing steps intended to reduce this risk; no documented human prion transmission from porcine hypothalamic supplements has been recorded. Potential pharmacodynamic interactions exist with corticosteroids, ACTH-based medications, somatostatin analogs (e.g., octreotide), and [thyroid](/ingredients/condition/hormonal) medications, as the extract's neuropeptide content could theoretically augment or interfere with their receptor-level activity. Safety data in pregnancy, lactation, pediatric populations, and individuals with autoimmune or endocrine disorders is entirely lacking, and use in these groups is not recommended.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were identified for porcine hypothalamus extract. Research consists primarily of in vitro studies and animal models from the 1970s-1980s, such as purified CRF fractions stimulating ACTH release in rat pituitary cells at doses of 50-200 μg/ml.

## Historical & Cultural Context

No evidence of traditional medicinal use for porcine hypothalamus extract was found in historical systems. Research originates from modern neuroendocrine studies in the 1970s-1980s focused on isolating hypothalamic releasing factors.

## Synergistic Combinations

Adrenal glandular extract, Vitamin B5, Ashwagandha, Phosphatidylserine, Rhodiola

## Frequently Asked Questions

### What is porcine hypothalamus extract used for in supplements?

Porcine hypothalamus extract is used in glandular supplement formulas primarily to support hypothalamic-pituitary-adrenal (HPA) axis function, often marketed for stress response, adrenal support, and neuroendocrine balance. The theoretical basis is that bioactive peptides such as CRF, TRH, and somatostatin from porcine tissue may supplement endogenous neuropeptide signaling, although oral bioavailability of intact hypothalamic peptides is scientifically questionable due to gastrointestinal proteolysis.

### Is porcine hypothalamus extract safe to take daily?

No long-term human safety studies exist for daily oral porcine hypothalamus extract supplementation, making it impossible to define a proven safe daily dose. Short-term use at typical commercial label doses (often 100–500 mg dried glandular material) has not been formally evaluated in controlled trials, and concerns include allergic reactions in pork-sensitive individuals and theoretical prion risk from CNS-derived animal tissue. Individuals with hormone-sensitive conditions or those taking corticosteroids, thyroid medications, or somatostatin analogs should consult a physician before use.

### Does porcine hypothalamus extract contain actual hormones?

Porcine hypothalamus extract contains neuropeptide hormones and releasing factors including corticotropin-releasing factor (CRF), thyrotropin-releasing hormone (TRH), and somatostatin, all of which are synthesized and secreted by hypothalamic neurons in pigs. However, commercial dried glandular preparations undergo processing that may degrade or denature a significant proportion of these peptides, and standard oral delivery exposes them to gastric acid and proteolytic enzymes that further reduce intact peptide content. The actual bioavailable hormone load in a commercially consumed dose has not been rigorously quantified.

### What are the antimitogenic peptides found in hypothalamus extract?

Antimitogenic peptides in hypothalamic extracts were first characterized in the 1970s by researchers including Linus Pauling-era collaborators and later laboratory groups who isolated low-molecular-weight fractions from bovine and porcine hypothalamic tissue that inhibited tumor cell proliferation in vitro. These peptides, sometimes collectively referenced under the designation 'antineoplastons' precursors or hypothalamic inhibitory fractions, showed activity against HeLa and murine cancer cell lines in culture, but no validated pharmaceutical-grade compound with confirmed structure has advanced through clinical trials from porcine hypothalamic sources specifically. Their precise molecular identity, targets, and relevance to oral supplement use remain poorly defined in peer-reviewed literature.

### How does porcine hypothalamus extract differ from adrenal cortex extract?

Porcine hypothalamus extract is derived from the hypothalamus, a forebrain structure that produces releasing hormones (CRF, TRH, GnRH) that regulate the pituitary gland, whereas adrenal cortex extract is sourced from the outer layer of the adrenal gland and contains steroid hormone precursors including cortisol, DHEA precursors, and aldosterone-related compounds. Hypothalamus extract acts upstream in the HPA axis by potentially influencing pituitary signaling, while adrenal cortex extract acts downstream by contributing glucocorticoid and mineralocorticoid substrate. Clinically, both lack robust human trial evidence, but adrenal cortex extracts have a longer documented use history in early 20th-century medicine and carry a more direct risk of steroid-related side effects at high doses.

### What is the difference between porcine hypothalamus extract and bovine hypothalamus extract?

Porcine (pig) and bovine (cow) hypothalamus extracts are both derived from animal brain tissue but differ in their source species and peptide profiles. Porcine extract is more commonly used in supplements due to closer physiological similarity to human neuroendocrine function and easier regulatory approval in many markets. While both may contain corticotropin-releasing factor and antimitogenic peptides, the exact concentration and bioactivity of these compounds can vary between species.

### Is porcine hypothalamus extract safe during pregnancy and lactation?

There is insufficient safety data on porcine hypothalamus extract use during pregnancy and lactation, and it should be avoided in these populations due to its potential effects on the pituitary-adrenal axis and hormone regulation. Pregnant and nursing women should consult with a healthcare provider before using any neuroendocrine-active supplements. The extract's effects on fetal development and breast milk composition have not been adequately studied in humans.

### How does porcine hypothalamus extract compare to synthetic corticotropin-releasing factor (CRF) supplements?

Porcine hypothalamus extract contains natural CRF alongside other peptides and bioactive compounds, whereas synthetic CRF is a single isolated molecule. The extract's multi-component profile may offer broader neuroendocrine support, but synthetic CRF provides more precise dosing and standardization. Evidence supporting both approaches remains limited to basic science and animal studies, with no head-to-head human clinical trials comparing their effectiveness.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*